Literature DB >> 23211534

Prevalence and associations of the use of proton-pump inhibitors in nursing homes: a cross-sectional study.

Philipe de Souto Barreto1, Maryse Lapeyre-Mestre, Céline Mathieu, Christine Piau, Catherine Bouget, Françoise Cayla, Bruno Vellas, Yves Rolland.   

Abstract

OBJECTIVES: Very scarce information is available about the use of proton-pump inhibitors (PPI) in nursing homes (NH). This study investigated the factors associated with PPI use among NH residents.
DESIGN: Cross-sectional
SETTING: One hundred seventy-five NHs in Midi-Pyrénées region, South-Western France. PARTICIPANTS: Data was collected for 6275 NH residents. Participants (73.7% women) were aged 86 years (± 8.2). MEASUREMENTS: NH staff sent participants' drug prescriptions to research team; they also recorded information on residents' health characteristics. A binary logistic regression was performed on PPI use.
RESULTS: PPI use was highly prevalent (n = 2 370, ie, 37.8%). Whilst peptic ulcer (OR 4.741; 95% CI 3.647-6.163) and nonsteroidal anti-inflammatory drugs (OR 2.124; 95% CI 1.528-2.951) were important indicators of PPI use, they explained just a small fraction of PPI prescriptions; most prescriptions were probably inappropriately related to a general condition of health vulnerability, reflected by polypharmacy and comorbidities.
CONCLUSIONS: Vulnerable people take PPIs more often in NHs. Physicians must be aware about the health risks possibly induced by inappropriate PPI use when prescribing these drugs for NH residents.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211534     DOI: 10.1016/j.jamda.2012.10.018

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  17 in total

Review 1.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

2.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

3.  Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention.

Authors:  Cristina Silva; Célia Ramalho; Isabel Luz; Joaquim Monteiro; Paula Fresco
Journal:  Int J Clin Pharm       Date:  2015-01-31

4.  The nursing home population: an opportunity to make advances on research on multimorbidity and polypharmacy.

Authors:  P de Souto Barreto; B Vellas; J E Morley; Y Rolland
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

5.  Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan.

Authors:  K L Moore; W J Boscardin; M A Steinman; J B Schwartz
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

6.  Proton pump inhibitors and risk of dementia.

Authors:  Karn Wijarnpreecha; Charat Thongprayoon; Panadeekarn Panjawatanan; Patompong Ungprasert
Journal:  Ann Transl Med       Date:  2016-06

7.  Editorial: Frailty and Polypharmacy.

Authors:  Y Rolland; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

8.  Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.

Authors:  Kate N Wang; J Simon Bell; Edwin C K Tan; Julia F M Gilmartin-Thomas; Michael J Dooley; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

9.  Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.

Authors:  Charlène Cool; Philippe Cestac; Cécile McCambridge; Laure Rouch; Philipe de Souto Barreto; Yves Rolland; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

Review 10.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.